Clinical Trial

Pulsed Electric Field Ablation for Metastatic Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-07-01 -> 2028-08-01 2026-07-07
minor Completion pushed: 2028-07-01 -> 2028-08-01 2026-07-07
Trial Details
NCT Number NCT07487844
Lead Sponsor University of California, San Francisco
Collaborators: Galvanize Therapeutics, Inc., Society of Interventional Radiology Foundation
Conditions Metastatic Breast Cancer, Breast Cancer
Enrollment 20 participants
Start Date 2026-08-15
Primary Completion 2028-08-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-06